{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22130916", "DateCompleted": {"Year": "2012", "Month": "10", "Day": "09"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s00405-011-1856-8"], "ArticleDate": [{"Year": "2011", "Month": "12", "Day": "01"}], "Journal": {"ISSN": "1434-4726", "JournalIssue": {"Volume": "269", "Issue": "6", "PubDate": {"Year": "2012", "Month": "Jun"}}, "Title": "European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery", "ISOAbbreviation": "Eur Arch Otorhinolaryngol"}, "ArticleTitle": "Impact of ozone exposure on prostaglandin release in nasal polyps.", "Pagination": {"StartPage": "1623", "EndPage": "1628", "MedlinePgn": "1623-8"}, "Abstract": {"AbstractText": ["A dysregulation of the cyclooxygenases and a leukotriene/prostaglandin imbalance are assumed to be part of the pathogenesis of the aspirin (ASA) intolerance syndrome. Ozone is an air pollutant with known proinflammatory effects on exposed epithelia, however, its impact on the expression of the cyclooxygenases 1 and 2 (cox1/2) and prostaglandin E(2) (PGE(2)) in the nasal mucosa is not well known. Therefore, we analyzed cox expression and PGE(2) levels after ozone exposure in nasal mucosa and in nasal polyps considering ASA intolerance. Isolated epithelial nasal cells from control subjects without chronic rhinosinusitis (CRS), and those from patients with nasal polyps with and without ASA intolerance were cultured and exposed in vitro to ozone. Cox1/2 expression levels were analyzed by immunohistochemistry and PGE(2) release by ELISA. After ozone exposure cox1/2 expression remained unchanged in all the three groups. PGE(2) release was lowered in cell cultures from controls and from polyps of ASA tolerant but not in those of ASA intolerant patients after ozone exposure. In the latter, PGE(2) expression remained unchanged. Our in vitro data suggest that aspirin tolerant patients with polyps might be more affected by ozone compared to aspirin intolerant ones. The potential clinical impact of impaired PGE(2) expression caused by ozone on the functions of respiratory epithelia remains to be clarified."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Otolaryngology, Head and Neck Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55101 Mainz, Germany."}], "Identifier": [], "LastName": "Zhu", "ForeName": "Cheng Jing", "Initials": "CJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fruth", "ForeName": "Kai", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Schneider", "ForeName": "Astrid", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mann", "ForeName": "Wolf J", "Initials": "WJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Brieger", "ForeName": "Juergen", "Initials": "J"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Eur Arch Otorhinolaryngol", "NlmUniqueID": "9002937", "ISSNLinking": "0937-4477"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Prostaglandins"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 1"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Air Pollutants"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Cell Survival"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Cyclooxygenase 1"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Dinoprostone"}, {"QualifierName": [], "DescriptorName": "Endoscopy"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunohistochemistry"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["diagnostic imaging", "metabolism", "pathology"], "DescriptorName": "Nasal Polyps"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Prostaglandins"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Respiratory Mucosa"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": [], "DescriptorName": "Tomography, X-Ray Computed"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Am J Rhinol. 2005 Jan-Feb;19(1):7-13", "ArticleIdList": ["15794068"]}, {"Citation": "Br J Pharmacol. 2006 Apr;147(7):707-13", "ArticleIdList": ["16432506"]}, {"Citation": "Am J Respir Crit Care Med. 2001 Sep 1;164(5):819-25", "ArticleIdList": ["11549539"]}, {"Citation": "Toxicol Appl Pharmacol. 1993 Feb;118(2):215-23", "ArticleIdList": ["8442000"]}, {"Citation": "Inflammation. 2004 Apr;28(2):105-14", "ArticleIdList": ["15379216"]}, {"Citation": "Eur J Pharmacol. 2000 Sep 8;403(3):267-75", "ArticleIdList": ["10973629"]}, {"Citation": "Clin Exp Immunol. 2004 Nov;138(2):317-22", "ArticleIdList": ["15498043"]}, {"Citation": "Environ Health Perspect. 2005 Jan;113(1):73-82", "ArticleIdList": ["15626651"]}, {"Citation": "Biochem Biophys Res Commun. 2000 Jul 14;273(3):811-5", "ArticleIdList": ["10891328"]}, {"Citation": "Am J Respir Crit Care Med. 1999 Dec;160(6):1934-42", "ArticleIdList": ["10588609"]}, {"Citation": "Proc Am Thorac Soc. 2007 Jul;4(3):240-6", "ArticleIdList": ["17607006"]}, {"Citation": "Rhinology. 2007 Jun;45(2):97-101", "ArticleIdList": ["17708455"]}, {"Citation": "Am J Physiol. 1997 May;272(5 Pt 1):L879-87", "ArticleIdList": ["9176252"]}, {"Citation": "Respir Med. 2002 May;96(5):352-8", "ArticleIdList": ["12113386"]}, {"Citation": "Chest. 2004 Jun;125(6):2328-35", "ArticleIdList": ["15189958"]}, {"Citation": "Am J Physiol. 1995 Dec;269(6 Pt 1):L734-43", "ArticleIdList": ["8572235"]}, {"Citation": "J Allergy Clin Immunol. 2004 Nov;114(5):1116-23", "ArticleIdList": ["15536419"]}, {"Citation": "Clin Exp Allergy. 2003 Jun;33(6):777-82", "ArticleIdList": ["12801312"]}, {"Citation": "JAMA. 2004 Nov 17;292(19):2372-8", "ArticleIdList": ["15547165"]}, {"Citation": "Environ Health Perspect. 1992 Jul;97:95-101", "ArticleIdList": ["1396473"]}, {"Citation": "Eur Respir J. 2002 Oct;20(4):899-906", "ArticleIdList": ["12412681"]}, {"Citation": "Free Radic Biol Med. 2004 Mar 1;36(5):673-81", "ArticleIdList": ["14980710"]}, {"Citation": "J Leukoc Biol. 2004 Jul;76(1):227-36", "ArticleIdList": ["15075356"]}, {"Citation": "Br J Pharmacol. 1997 Mar;120(5):910-6", "ArticleIdList": ["9138698"]}, {"Citation": "Am J Rhinol. 2005 Mar-Apr;19(2):111-6", "ArticleIdList": ["15921208"]}, {"Citation": "Curr Opin Pulm Med. 2004 Jan;10(1):51-6", "ArticleIdList": ["14749606"]}, {"Citation": "ORL J Otorhinolaryngol Relat Spec. 2007;69(5):277-82", "ArticleIdList": ["17565230"]}, {"Citation": "Allergy. 2008 Apr;63(4):438-46", "ArticleIdList": ["18315731"]}, {"Citation": "Toxicol Appl Pharmacol. 1997 Mar;143(1):96-101", "ArticleIdList": ["9073597"]}, {"Citation": "Toxicol Sci. 2001 Apr;60(2):356-62", "ArticleIdList": ["11248148"]}, {"Citation": "JAMA. 2003 Oct 8;290(14):1859-67", "ArticleIdList": ["14532314"]}, {"Citation": "ORL J Otorhinolaryngol Relat Spec. 2005;67(3):125-36", "ArticleIdList": ["15942266"]}, {"Citation": "Toxicol Lett. 2007 Jun 15;171(1-2):29-37", "ArticleIdList": ["17498896"]}]}], "History": [{"Year": "2011", "Month": "8", "Day": "22"}, {"Year": "2011", "Month": "11", "Day": "17"}, {"Year": "2011", "Month": "12", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "12", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "10", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22130916", "10.1007/s00405-011-1856-8"]}}], "PubmedBookArticle": []}